The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Hjorth CF, Damkier P, Stage TB, Feddersen S, et al. Cancer Chemother Pharmacol 2023 Jan 4. doi: 10.1007/s00280-022-04499.

Read + Share

Amedeo Smart

Independent Medical Education

Hjorth CF, Damkier P, Stage TB, Feddersen S, et al. The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Cancer Chemother Pharmacol 2023 Jan 4. doi: 10.1007/s00280-022-04499.
PMID: 36598552